ClinConnect ClinConnect Logo
Search / Trial NCT06604000

Goal Management Training (GMT) for Improvement of Cognitive Control Function After Acquired Brain Injury

Launched by ST. OLAVS HOSPITAL · Sep 16, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Acquired Brain Injury Goal Management Training Executive Function Cognitive Control Gmt Cognitive Rehabilitation

ClinConnect Summary

This clinical trial is studying a type of therapy called Goal Management Training (GMT) to see how it can help improve thinking skills in people who have had an acquired brain injury (ABI). The researchers want to find out what factors, like age or previous health conditions, can predict how well someone will respond to the treatment. They will also look at how using a smartphone app for reminders, and an extra follow-up session, may help patients remember and apply what they learned during their training.

To take part in the trial, participants need to be between 18 and 65 years old and have experienced an ABI at least a year ago, with ongoing difficulties in cognitive control (the ability to manage thoughts and actions). Participants will join small groups for 10 training sessions over five weeks, and they will complete surveys and cognitive tests at different points to track their progress. It's important to note that people with certain language or mental health issues, as well as those who are not fluent in Norwegian, won't be eligible to participate. This trial is currently looking for volunteers to help improve treatment options for cognitive challenges after brain injuries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 18-65 with acquired brain injury with no concomitant diseases minimum 12 months' post-injury/surgery, reporting cognitive control problems by structured interview or clinical performance measures.
  • Exclusion Criteria:
  • Non-fluency in Norwegian Language
  • Major psychiatric disorder or reported ongoing alcohol or substance abuse.
  • Premorbid neurological disease or insult and/or comorbid neurological disease.
  • Aphasia or other specified language problems causing potential communication problems.
  • Impaired basic linguistic, mnemonic, motor, or perceptual function that can interfere with the ability to engage with training or estimated IQ \< 85

About St. Olavs Hospital

St. Olavs Hospital is a leading healthcare institution located in Trondheim, Norway, renowned for its commitment to advancing medical research and improving patient care. As a key clinical trial sponsor, the hospital is dedicated to conducting innovative research across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With state-of-the-art facilities and a patient-centric approach, St. Olavs Hospital aims to enhance clinical outcomes and contribute to the global body of medical knowledge through rigorous and ethically conducted clinical trials.

Locations

Trondheim, , Norway

Patients applied

0 patients applied

Trial Officials

Alexander Olsen

Principal Investigator

National Taiwan Normal University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported